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Abstract
Background: The evidence for an association between insomnia symptoms and blood hemoglobin A1c (HbA1c) level has
been limited and inconclusive. The aim of this study was to assess whether each symptom of initial, middle, and terminal
insomnia influences HbA1c level in Japanese men.
Methods: This cross-sectional study examined 1,022 male workers aged 22–69 years with no history of diabetes at a
Japanese company’s annual health check-up in April 2010. High HbA1c was defined as a blood level of HbA1c $6.0%. Three
types of insomnia symptoms (i.e., difficulty in initiating sleep, difficulty in maintaining sleep, and early morning awakening)
from the previous month were assessed by 3 responses (i.e., lasting more than 2 weeks, sometimes, and seldom or never
[reference group]).
Results: The overall prevalence of high HbA1c was 5.2%. High HbA1c was positively and linearly associated with both
difficulty in maintaining sleep (P for trend =.002) and early morning awakening (P for trend =.007). More specifically, after
adjusting for potential confounding factors, high HbA1c was significantly associated with difficulty in maintaining sleep
lasting more than 2 weeks (adjusted odds ratio, 6.79 [95% confidence interval, 1.86–24.85]) or sometimes (2.33 [1.19–4.55]).
High HbA1c was also significantly associated with early morning awakening lasting more than 2 weeks (3.96 [1.24–12.59]).
Conclusion: Insomnia symptoms, particularly difficulty in maintaining sleep and early morning awakening, were found to
have a close association with high HbA1c in a dose-response relationship.
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Introduction
The prevalence of diabetes has been increasing in Japan, and
the total number of Japanese with hyperglycemia was estimated to
have risen from 14 million in 1997 to 22 million in 2007 [1].
Diabetes imposes a substantial burden in terms of premature
mortality and health care costs [2]; therefore, the prevention of
diabetes is recognized as an urgent public health priority.
A growing body of evidence suggests that insomnia is
bidirectionally associated with diabetes. Insomnia can be second-
ary to diabetes because of diabetic complications or the
psychological stress associated with diabetes management [3–5].
However, insomnia can also play an important role in the
pathogenesis of diabetes. A recent systematic review and meta-
analysis of 5 longitudinal studies showed that the major symptom
of insomnia (i.e., difficulty in initiating or maintaining sleep)
significantly predicts the risk for developing diabetes [6]. To help
in the prevention and treatment of diabetes, it may be useful to
clarify the effect of insomnia on glycemic status.
The blood level of hemoglobin A1c (HbA1c) is perceived as the
gold standard for monitoring glycemic control and is recom-
mended as a diagnostic criterion for diabetes [7,8]. However, only
2 cross-sectional studies have assessed the effect of insomnia
symptoms on HbA1c level. Knutson et al. [9] found a significant
association between poor sleep quality and increased HbA1c level
in African-American patients with type 2 diabetes. In contrast,
Nakajima et al. [10] did not find a significant association between
insomnia symptoms and HbA1c level in a Japanese non-patient
population. Thus, the association between insomnia symptoms
and HbA1c level has been inconclusive.
The aim of the present study was to assess the association
between insomnia symptoms and HbA1c level in Japanese men.
Although most previous studies have been limited by an
inadequate assessment of insomnia symptoms [6] (e.g., they did
not specify the time frame), we specified the duration of insomnia
symptoms according to the criteria of the Diagnostic and
Statistical Manual of Mental Disorders, Fourth Edition, Text
Revision (DSM-IV-TR) [11].
Materials and Methods
Procedures and participants
This cross-sectional study was conducted in April 2010 as part
of a Japanese company’s annual health check-up, regulated by the
Industrial Safety and Health Act. The participants in the study
were full-time office workers at a general trading company in
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explaining the study’s purpose and procedures, was distributed to
all employees (n=1,313) before the health check-up; 1,284
provided written informed consent to participate in the study
and returned the questionnaire during the health check-up
(response rate, 98%). Of these, 174 women were excluded because
of the small sample size, and 88 men were excluded because of
previously diagnosed or treated diabetes (n=54) or missing data
on any of the included variables (n=34). A total of 1,022 men
without previously diagnosed or treated diabetes were included in
the analysis.
The present study was conducted according to the principles
expressed in the Declaration of Helsinki. The protocol was
approved by the Ethical Review Committee at Teikyo University
School of Medicine.
Outcome: high HbA1c level
After an overnight fast, blood samples for HbA1c were collected
between 0800 and 1130 h. As the HbA1c level is relatively stable
over time within individuals [7], differences in fasting duration
may not influence the HbA1c values. The value for HbA1c (%) is
estimated as an National Glycohemoglobin Standardization
Program (NGSP) equivalent value (%) calculated by the formula
HbA1c (%)=HbA1c (Japan Diabetes Society [JDS]) (%) +0.4%,
taking into consideration the relational expression of HbA1c (JDS)
(%) measured by the previous Japanese standard substance and
measurement methods and HbA1c (NGSP).
High HbA1c was defined as a blood level of HbA1c $6.0%,
which is the cutoff point for highly probable diabetes according to
the definition of the Japan Diabetes Society [8]. This definition is
in agreement with the International Expert Committee’s recom-
mendation that diabetes is to be diagnosed if the HbA1c level is
$6.5%, and that individuals with an HbA1c $6.0% but ,6.5%
are likely to be at the highest risk for developing diabetes [7].
Exposure: insomnia symptoms
Three types of insomnia symptoms from the previous month
were assessed using the following questions: ‘‘Do you have
difficulty falling asleep at night?’’ (difficulty in initiating sleep),
‘‘Do you wake up during the night after you have gone to sleep?’’
(difficulty in maintaining sleep), and ‘‘Do you wake up too early in
the morning and have difficulty getting back to sleep?’’ (early
morning awakening). For each question, 3 response options were
offered: ‘‘lasting more than 2 weeks,’’ ‘‘sometimes,’’ and ‘‘seldom
or never.’’ Insomnia symptoms lasting more than 2 weeks are in
line with the DSM-IV-TR definition of insomnia [11]. These
questions were adopted from our previous studies [12,13], and the
answers were confirmed by 2 male physicians specializing in
psychiatry according to the DSM-IV-TR definition of insomnia
[11].
Covariates
Covariates were selected from established diabetes risk factors
[14] and included age (continuous), body mass index (BMI;
continuous), sleep duration (,6o r$6 hours per night), smoking
status (never, past, or current), drinking habit (never, occasional, or
daily), regular physical activity (yes or no), and family history of
diabetes (yes or no). BMI was calculated by dividing the measured
weight in kilograms by the square of the measured height in
meters. Sleep duration of less than 6 hours has been shown to be
associated with an increased risk for type 2 diabetes [6]. Regular
physical activity was defined as continuing for at least 30 minutes,
2 times/week, for more than 1 year.
Statistical analyses
First, the characteristics of the participants were compared
across the 3 categories of each insomnia symptom. Second, the
Mantel-Haenszel chi-square test for linear trend was used to
determine the trend in the prevalence rates of high HbA1c across
the 3 categories of each insomnia symptom. Third, logistic
regression models were used to assess the effect of each insomnia
symptom on the risk for high HbA1c after adjusting the covariates.
Results were shown as odds ratios (ORs) with 95% confidence
intervals (CIs). Three models were used, each with a different
independent variable: model 1, difficulty in initiating sleep; model
2, difficulty in maintaining sleep; and model 3, early morning
awakening. Finally, a sensitivity analysis was performed to evaluate
the robustness of the results by treating blood levels of HbA1c as a
continuous variable. Multiple regression analyses were performed
to assess the effect of each insomnia symptom on continuous
HbA1c levels after adjusting the covariates. There were no
multicollinearity problems, and the residuals followed a normal
distribution. All statistical tests were 2-sided, with a 5%
significance level. All analyses were conducted using SAS Version
9.2 for Windows (SAS, Inc., Cary, NC).
Results
Among the 1,022 participants included in the analysis, the mean
and standard deviation values were 43.9610.1 years (range, 22–69
years) for age, 24.163.3 kg/m
2 for BMI, and 5.06.4% for HbA1c
level. The distributions of insomnia symptoms were as follows: 1.5%
of participants reported difficulty in initiating sleep lasting more than
2 weeks, 21.2% reported sometimes, and 77.3% reported seldom or
never; 2.4% of participants reported difficulty in maintaining sleep
lasting more than 2 weeks, 21.4% reported sometimes, and 76.2%
reported seldom or never; and 3.4% of participants reported early
morning awakening lasting more than 2 weeks, 29.6% reported
sometimes, and 67.0% reported seldom or never. These distributions
were almost identical to those from a previous Japanese nationwide
study that used the same definitions for insomnia symptoms as those
in our study [12]. Participants with a higher frequency of any type of
insomnia symptoms were more likely to be older, to sleep less, and to
not engage in regular physical activity (Table 1). In addition,
participants with any type of insomnia symptoms lasting more than 2
w e e k sw e r em o r el i k e l yt ob ep a s ts m o k e r s( T a b l e1 ) .
The overall prevalence of high HbA1c was 5.2%. There was a
significant and graded positive association of difficulty in
maintaining sleep (P for trend =.002) and early morning
awakening (P for trend =.007) with the prevalence of high
HbA1c (Figure 1). However, such a linear trend was not observed
regarding difficulty in initiating sleep (P for trend =.953), and
none of the participants in the ‘‘lasting more than 2 weeks’’
category of difficulty in initiating sleep had high HbA1c.
Table 2 shows ORs of high HbA1c as computed using logistic
regression models. In model 1, no significant association was
observed between difficulty in initiating sleep and high HbA1c.I n
model 2, participants who experienced difficulty in maintaining
sleep lasting more than 2 weeks (adjusted OR 6.79 [95% CI 1.86–
24.85]) or sometimes (2.33 [1.19–4.55]) were significantly more
likely to have high HbA1c, compared with those who experienced
this seldom or never. In model 3, participants who experienced
early morning awakening lasting more than 2 weeks (3.96 [1.24–
12.59]) were significantly more likely to have high HbA1c,
compared with those who experienced this seldom or never.
Similar associations were observed in multiple regression models
as sensitivity analyses (Table S1). After adjusting for all covariates
including age, BMI, sleep duration, smoking status, drinking habits,
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maintaining sleep and early morning awakeninglastingmore than 2
weeks were found to be significantly associated with continuous
HbA1c levels. However, no significant association was observed
between difficulty in initiating sleep and continuous HbA1c levels.
Discussion
We found that difficulty maintaining sleep and early morning
awakening were significantly associated with HbA1c level in a
dose-response relationship in Japanese men. These associations
were independent of age, BMI, sleep duration, smoking status,
drinking habit, regular physical activity, and family history of
diabetes. The results are consistent with the findings of a previous
longitudinal study indicating that difficulty in initiating or
maintaining sleep is related to incident diabetes [6] and those of
a previous cross-sectional study indicating that poor sleep quality
affects glycemic control, as assessed by HbA1c level among patients
with type 2 diabetes [9]. The observed dose-response associations
suggest that not only insomnia at a clinical level but also milder
Table 1. Characteristics of participants, by 3 categories of each insomnia symptom (n=1,022).
Difficulty in initiating sleep Difficulty in maintaining sleep Early morning awakening
Lasting
more Sometimes Seldom or
Lasting
more Sometimes Seldom or
Lasting
more Sometimes Seldom or
than 2
weeks never
than 2
weeks never
than 2
weeks never
Characteristics (n=15) (n=217) (n=790) (n=24) (n=219) (n=779) (n=35) (n=302) (n=685)
Age (y) 45.869.1 42.769.7 44.2610.2 47.068.5 44.669.5 43.6610.2 48.169.7 46.369.5 42.6610.1
Body mass index (kg/m
2)2 3 . 9 63.2 24.063.4 24.263.2 24.363.8 24.263.3 24.163.3 23.963.5 24.263.2 24.163.3
Sleep duration ,6 h 11 (73.3) 115 (53.0) 341 (43.2) 17 (70.8) 118 (53.9) 332 (42.6) 24 (68.6) 141 (46.7) 302 (44.1)
Smoking status
Current 3 (20.0) 97 (44.7) 253 (32.0) 3 (12.5) 76 (34.7) 274 (35.2) 5 (14.3) 98 (32.5) 250 (36.5)
Past 8 (53.3) 54 (24.9) 283 (35.8) 16 (66.7) 72 (32.9) 257 (33.0) 20 (57.1) 116 (38.4) 209 (30.5)
Never 4 (26.7) 66 (30.4) 254 (32.2) 5 (20.8) 71 (32.4) 248 (31.8) 10 (28.6) 88 (29.1) 226 (33.0)
Drinking habit
Every day 3 (20.0) 77 (35.5) 294 (37.2) 8 (33.3) 95 (43.4) 271 (34.8) 12 (34.3) 139 (46.0) 223 (32.6)
Occasional 7 (46.7) 102 (47.0) 366 (46.3) 12 (50.0) 96 (43.8) 367 (47.1) 15 (42.9) 127 (42.1) 333 (48.6)
Never 5 (33.3) 38 (17.5) 130 (16.5) 4 (16.7) 28 (12.8) 141 (18.1) 8 (22.9) 36 (11.9) 129 (18.8)
Regular physical activity
a 2 (13.3) 72 (33.2) 337 (42.7) 5 (20.8) 83 (37.9) 323 (41.5) 11 (31.4) 115 (38.1) 285 (41.6)
Family history of diabetes 2 (13.3) 30 (13.8) 101 (12.8) 2 (8.3) 36 (16.4) 95 (12.2) 3 (8.6) 49 (16.2) 81 (11.8)
Data are mean 6 SD or n (%). sPercentages may not add up to 100 because of rounding.
aRegular physical activity was defined as continuing at least 30 minutes, 2 times/week, for more than a year.
doi:10.1371/journal.pone.0021420.t001
Figure 1. The prevalence of high HbA1c across 3 categories of difficulty in maintaining sleep and early morning awakening. High
HbA1c is defined as a blood level of hemoglobin A1c $6.0%. P values were obtained from the Mantel-Haenszel chi-square test for linear trend.
doi:10.1371/journal.pone.0021420.g001
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dose-response associations also suggest that individuals with
greater duration of insomnia symptoms may have higher HbA1c
levels. However, no significant association was observed between
difficulty in initiating sleep and HbA1c level, possibly due to a lack
of statistical power from having a small number of men who
reported difficulty in initiating sleep (n=15). The results revealed
that a relatively small number of the participants with a clinical or
milder level of any insomnia symptoms had high HbA1c. For
example, only four were identified as having high HbA1c among
24 participants with difficulty in maintaining sleep lasting more
than 2 weeks, and five among 35 participants with early morning
awakening. However, such participants met the clinical DSM-IV-
TR criteria for insomnia, and need to be managed appropriately
because they had high risks for a variety of mind/body illness
including type 2 diabetes and depression. In addition, considering
that insomnia is common in today’s society, the combined effect of
clinical and mild insomnia on type 2 diabetes may be considerable.
Unlike the previous cross-sectional study by Nakajima et al.
[10], we observed a significant association between the major
symptoms of insomnia and HbA1c level in a Japanese non-patient
population. The discrepancy between the 2 studies may be partly
due to a difference in the definition of insomnia symptoms. In the
previous study [10], the presence of insomnia was defined as
symptoms occurring ‘‘3 times or more per week,’’ which was not
based on clinical diagnostic criteria such as the DSM-IV-TR.
The mechanisms underlying the association between insomnia
symptoms and HbA1c level are unclear. However, several factors
associated with insomnia symptoms, including obesity-promoting
health behaviors (e.g., reduced energy expenditure and increased
food intake) [15] and activation of the sympathetic nervous system
and the hypothalamic-pituitary-adrenal axis [16,17], can cause
insulin resistance and increase the risk for diabetes. Additionally,
our results showing that men with insomnia symptoms at a clinical
level were more likely to be past smokers and that current smoking
was significantly associated with high HbA1c provided insight into
the mechanism; smoking may confound the association. Smoking
is known to be associated with both depression (which is frequently
accompanied by insomnia) [18] and type 2 diabetes [19]. Further
research is required to explore the underlying mechanisms.
The strengths of our study include a homogeneous study
population, a high response rate, accurately defined exposure
Table 2. Odds ratios (ORs) for high HbA1c
a according to each of 3 types of insomnia symptoms (n=1,022).
Model 1 Model 2 Model 3
Variables OR (95% CI) OR (95% CI) OR (95% CI)
Difficulty in initiating sleep
Lasting more than 2 weeks N/A — —
Sometimes 1.54 (0.75–3.14) — —
Seldom or never 1.00 — —
Difficulty in maintaining sleep
Lasting more than 2 weeks — 6.79 (1.86–24.85)
* —
Sometimes — 2.33 (1.19–4.55)
* —
Seldom or never — 1.00 —
Early morning awakening
Lasting more than 2 weeks — — 3.96 (1.24–12.59)
*
Sometimes — — 1.27 (0.67–2.41)
Seldom or never — — 1.00
Age (y) 1.11 (1.07–1.15)
* 1.11 (1.07–1.15)
* 1.10 (1.06–1.14)
*
Body mass index (kg/m
2) 1.27 (1.16–1.38)
* 1.27 (1.17–1.39)
* 1.27 (1.17–1.39)
*
Sleep duration ,6 h 0.69 (0.36–1.30) 0.54 (0.28–1.05) 0.60 (0.31–1.15)
Smoking status
Current 2.46 (0.99–6.12) 2.71 (1.08–6.80)
* 2.59 (1.04–6.46)
*
Past 2.30 (0.94–5.62) 2.12 (0.86–5.23) 2.08 (0.85–5.11)
Never 1.00 1.00 1.00
Drinking habit
Every day 1.04 (0.41–2.64) 0.94 (0.37–2.39) 0.99 (0.39–2.53)
Occasional 1.00 (0.40–2.54) 0.88 (0.34–2.24) 0.94 (0.37–2.39)
Never 1.00 1.00 1.00
Regular physical activity
b 1.35 (0.74–2.46) 1.51 (0.82–2.78) 1.36 (0.75–2.48)
Family history of diabetes 1.84 (0.87–3.89) 1.90 (0.89–4.05) 1.79 (0.84–3.80)
CI, confidence interval.
*P,0.05.
A dash (—) indicates that the item was not included in the model.
aHigh HbA1c was defined as a blood level of hemoglobin A1c $6.0%.
bRegular physical activity was defined as continuing for at least 30 minutes, 2 times/week, for more than a year.
doi:10.1371/journal.pone.0021420.t002
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However, our study has some limitations. First, because of the
cross-sectional nature of the study, we could not determine the
temporality of the association and exclude the possibility of reverse
causality. Indeed, preliminary analysis showed that the partici-
pants with previously diagnosed or treated diabetes had a higher
prevalence of any insomnia symptoms lasting more than 2 weeks
than analyzed participants (10.0% vs. 4.9%). Preliminary analyses
also showed more stable associations between insomnia symptoms
and high HbA1c levels when participants with previously
diagnosed or treated diabetes were included in the analyses (Table
S2, Table S3). However, we were able to minimize the possibility
of reverse causality by excluding participants with previously
diagnosed or treated diabetes. Second, the estimates of OR for
high HbA1c need to be interpreted with some caution because of
the potential for high variability associated with a small cell size.
Third, 3 types of insomnia symptoms assessed in this study are
general but limited aspects of insomnia. Impairment in daytime
functioning and subtypes based on etiology were not considered.
Additionally, insomnia symptoms were self-reported. However,
self-reports of insomnia symptoms, as used in this study, are the
measures most widely used in epidemiological surveys [6], and the
results were confirmed by two specialists in our study. Fourth,
although the quantitative aspect of sleep (i.e., short and long sleep
durations) is a risk factor for diabetes [6], we could not fully
consider the effect of sleep duration on high HbA1c because of the
inadequate assessment of sleep duration (i.e., few response
options). Fifth, although we considered a range of confounders,
unmeasured confounders that may be linked to both insomnia
symptoms and diabetes risk could have contributed to the
association. Examples of such possible confounders are obstructive
sleep apnea syndrome (OSAS) and restless legs syndrome (RLS).
OSAS is known to be associated with insomnia [20] and insulin
resistance [21]. In Japan, OSAS prevalence in adult males was
estimated to be 3.3% [22]. This significant number of OSAS cases
might contribute to the association between insomnia symptoms
and HbA1c level. RLS is also known to be associated with difficulty
in initiating and maintaining sleep and diabetes [23]. However,
because RLS prevalence in Asians (0.7%) has been reported to be
lower than that in Caucasians (5%–10%) [24,25], the confounding
effect of RLS might be small. Finally, the study population was
restricted to men, which limited the generalizability of the findings.
A Japanese national survey has shown that men are less likely to
report difficulty in initiating and maintaining sleep, but are more
likely to report early morning awakening compared to women [1].
Thus, insomnia symptoms might associate differently with HbA1c
level depending on the gender. Additionally, the sample of white-
collar workers also limits the generalizability of the findings.
However, the distribution of each insomnia symptom in our
sample was almost identical to that in the general Japanese
population [12].
In summary, the present study suggests that insomnia
symptoms, particularly difficulty in maintaining sleep and early
morning awakening, are closely associated in a dose-response
relationship with high HbA1c in Japanese men. Further studies are
required to elucidate the association between difficulty in initiating
sleep and HbA1c level. Health care practitioners may therefore
need to pay more attention to individuals with insomnia symptoms
to reduce the risk for diabetes.
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